Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in Primary Liver Cancer
2005-001503-19Phase 2Completed
- Sponsor
- European Institute of Oncology
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of thalidomide in hepatocellular carcinoma (HCC), sponsored by European Institute of Oncology. Started Sep 2005; status: completed.
02
Drugs
thalidomide
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on 2005-001503-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001503-19.